US-based health insurer Humana adjusts its annual earnings forecast upward, citing more stable medical costs and sustained performance in its Medicare Advantage business.
Humana raised its full-year profit projection after reporting a steady medical cost trend and stronger-than-expected membership numbers in its Medicare Advantage (MA) plans. The company, which plays a significant role in administering healthcare services to seniors and people with disabilities under US government-backed plans, said it expects reduced pressure from medical spending compared to the past two years. For the quarter, Humana reported a medical cost ratio of 89.7%, slightly higher than last year’s 88.9% but within the range expected by analysts.
According to The Economic Times, Chief Executive Officer Jim Rechtin said the company’s financial performance in the first half of the year reflected operational consistency and cost discipline. One of the key contributors to the results was the company’s CenterWell primary care unit, which continued to show strength. Humana also noted that membership in its individual MA plans declined less than earlier estimates. The company expects this trend, along with pricing adjustments in its insurance offerings, to support margin recovery through the rest of the year.
Humana now forecasts its full-year profit to reach around $17 per share, revising it up from a previous estimate of $16.25 per share. Market analysts had been expecting around $16.38, based on projections compiled by LSEG. For the latest quarter, the company posted earnings of $6.27 per share, exceeding consensus estimates of $5.92.
While the broader US insurance sector has been navigating higher-than-usual medical utilization patterns, Humana’s updated guidance signals a potential easing of those pressures. The company remains focused on managing its cost structure while reinforcing service delivery across its core Medicare Advantage portfolio.
